12
views
0
recommends
+1 Recommend
3 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      STIs and the COVID‐19 pandemic: the lockdown does not stop sexual infections

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Editor In December 2019, a novel coronavirus (SARS‐CoV‐2) emerged in Wuhan, China, responsible for an aggressive interstitial pneumonia. 1 Italy was the first Western country to be hit by the coronavirus disease 2019 (COVID‐19), and on 9 March, our Prime Minister announced a nationwide lockdown, strictly forbidding any contacts outside cohabitants, except for urgent or medical reasons. In compliance with the ministerial decree, all scheduled visits were suspended, maintaining hospital access only for emergencies. While the initial guidelines to reorganize medical activities during the pandemic were focused on the management of inflammatory, autoimmune and neoplastic disorders, scarce attention was paid to sexually transmitted infections (STIs) and STI clinics. We report here data of our STI clinic, one of the 12 Italian clinical sentinel sites for the surveillance of STIs, which is located in the Provincia Autonoma di Trento, the Italian district most affected by COVID‐19 (cumulative incidence: 1007.77 cases/100 000 inhabitants). 2 During the lockdown (9 March – 4 May), we diagnosed, by NAATs, 9 Chlamydia trachomatis infections and 2 Neisseria gonorrhoeae infections (one of these patients experienced a reinfection during the lockdown despite a negative‐tested partner), and 4 cases of syphilis (Table 1). Table 1 Age, sex, disease, onset of symptoms and history of exposure in the described population during the Italian lockdown (9 March‐4 May) Patient Age Sex STI DoD S.O. RRSB Note 1 25 M C. trachomatis 11 March 12 February NO Condom breaking 2 26 M C. trachomatis 25 March 16 March NO Known infection in the partner 3 32 M C. trachomatis 25 March 15 March YES 4 30 M C. trachomatis 8 April 25 April YES 5 26 M C. trachomatis 8 April 14 March YES Unprotected sexual intercourse on 9 March 6 31 M C. trachomatis 29 April 29 February YES N.gonorrhoeae 3 years before 7 28 F C. trachomatis 10 March N.S. YES Known infection in the partner 8 21 F C. trachomatis 22 April 21 March NO Known infection in the partner 9 21 F C. trachomatis 1 May 23 March YES 10 38 M N. gonorrhoeae 16 March 6 March YES 2 N. gonorrhoeae infections during lockdown with negative‐tested partner 11 29 M N. gonorrhoeae 25 March 15 March YES 12 45 M Syphilis (Primary) 4 May 21 March YES Ongoing HIV‐PrEP 13 59 M Syphilis (Latent) 24 April NS NO Last negative serology dated 2016 14 21 F Syphilis (Latent) 3 April NS NO Unprotected sexual intercourse in December 2019 15 53 F Syphilis (Latent) 10 April NS NO DoD, date of diagnosis, F, female; M, male; N.S., no symptoms; PrEP, pre‐exposure prophylaxis; RRSB, referred risky sexual behaviour during lockdown; S.O., (referred) symptoms/signs onset; STI, sexually transmitted infection. John Wiley & Sons, Ltd This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency. Concerning the urethritis and cervicitis, symptoms were reported by 10 of 11 patients, while the last patient was asymptomatic but underwent testing because her partner had recently received a diagnosis of C. trachomatis infections. Regarding the cases of syphilis, 3 were latent, and 1 was primary. Of these 15 STIs, 9 patients referred risky sexual behaviour during lockdown. In the same period in 2019, we had diagnosed 17 STIs: 6 C. trachomatis infections, 7 N. gonorrhoeae infections, 1 concomitant infection of C. trachomatis and N. gonorrhoeae, and 3 latent syphilis. Therefore, the incidence was comparable, despite the unlimited number of daily accesses possible in 2019. Common sense suggests that social isolation and the closure of leisure venues may significantly reduce the opportunity for casual sexual encounters, and some authors suggested that quarantine and social distancing measures might reduce the incidence of STIs in the future. 3 However, our recent experience strengthened the lesson learned from the AIDS epidemic: ‘not having sex is not an option’. Even though resources from health systems are often redirected in response to an outbreak, crucial healthcare services should remain accessible during public health emergencies. 4 Therefore, we suggest that visits of STI patients should not be cancelled, making use of teledermatology where possible and visiting any doubtful cases. Moreover, patients should not be discouraged to seek STI screening, because risky behaviours do not seem to decrease during the pandemic and, not least, a delay in diagnosis could result in sequelae and complications. Finally, our key message is a reiteration, referred to STIs, of the WHO Director‐General’s words during the pandemic: ‘We have a simple message for all countries: test, test, test’. 5 All authors have agreed to the contents of the manuscript in its submitted form. Funding sources None. Conflict of interest The authors have no conflict of interest to disclose. References 1 Huang C , Wang Y , Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506.31986264 2 https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino‐sorveglianza‐integrata‐COVID‐19_16‐giugno‐2020.pdf (last access 23 June 2020). 3 Alpalhão M , Filipe P . The impacts of isolation measures against SARS‐CoV‐2 infection on sexual health. AIDS Behav 2020; 1–2. [Epub ahead of print] 10.1007/s10461-020-02853-x 30903450 4 Tran NT , Tappis H , Spilotros N , Krause S , Knaster S . Inter‐Agency Working Group on Reproductive Health in Crises. Not a luxury: a call to maintain sexual and reproductive health in humanitarian and fragile settings during the COVID‐19 pandemic. Lancet Glob Health. 2020; 8: e760–e761.32330429 5 https://www.who.int/dg/speeches/detail/who‐director‐general‐s‐opening‐remarks‐at‐the‐media‐briefing‐on‐covid‐19–‐16‐march‐2020 (last access 22 May 2020).

          Related collections

          Most cited references3

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

          Summary Background A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients. Methods All patients with suspected 2019-nCoV were admitted to a designated hospital in Wuhan. We prospectively collected and analysed data on patients with laboratory-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing. Data were obtained with standardised data collection forms shared by WHO and the International Severe Acute Respiratory and Emerging Infection Consortium from electronic medical records. Researchers also directly communicated with patients or their families to ascertain epidemiological and symptom data. Outcomes were also compared between patients who had been admitted to the intensive care unit (ICU) and those who had not. Findings By Jan 2, 2020, 41 admitted hospital patients had been identified as having laboratory-confirmed 2019-nCoV infection. Most of the infected patients were men (30 [73%] of 41); less than half had underlying diseases (13 [32%]), including diabetes (eight [20%]), hypertension (six [15%]), and cardiovascular disease (six [15%]). Median age was 49·0 years (IQR 41·0–58·0). 27 (66%) of 41 patients had been exposed to Huanan seafood market. One family cluster was found. Common symptoms at onset of illness were fever (40 [98%] of 41 patients), cough (31 [76%]), and myalgia or fatigue (18 [44%]); less common symptoms were sputum production (11 [28%] of 39), headache (three [8%] of 38), haemoptysis (two [5%] of 39), and diarrhoea (one [3%] of 38). Dyspnoea developed in 22 (55%) of 40 patients (median time from illness onset to dyspnoea 8·0 days [IQR 5·0–13·0]). 26 (63%) of 41 patients had lymphopenia. All 41 patients had pneumonia with abnormal findings on chest CT. Complications included acute respiratory distress syndrome (12 [29%]), RNAaemia (six [15%]), acute cardiac injury (five [12%]) and secondary infection (four [10%]). 13 (32%) patients were admitted to an ICU and six (15%) died. Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα. Interpretation The 2019-nCoV infection caused clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and was associated with ICU admission and high mortality. Major gaps in our knowledge of the origin, epidemiology, duration of human transmission, and clinical spectrum of disease need fulfilment by future studies. Funding Ministry of Science and Technology, Chinese Academy of Medical Sciences, National Natural Science Foundation of China, and Beijing Municipal Science and Technology Commission.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The Impacts of Isolation Measures Against SARS-CoV-2 Infection on Sexual Health

            The recently discovered SARS-CoV-2, the cause of COVID-19, has raised significant challenges to society as a whole. The recommended social isolation measures that have been adopted worldwide to control this pandemic are of a magnitude never before seen in modern history. Such measures have wide reaching consequences, many of which are not yet known. While physical distancing and social isolation may directly impact both the physical and psychological health of individuals, a cohort effect on public health must be considered. One such area where we may see significant ancillary ramifications of COVID-19 pertains to sexual health. Social isolation and the closure of leisure venues may significantly reduce the opportunity for casual sexual encounters. We may well see, in the forthcoming months, a significant reduction in the incidence of sexually transmissible infections (STIs). Many countries have seen marked increases in their incidence of syphilis, chlamydia and gonorrhea in the last few years. For instance, it is estimated that in the United States between 2014 and 2018 syphilis, chlamydia, and gonorrhea have increased in incidence by 71%, 19%, and 63%, respectively [1]. In contrast, HIV incidence has been decreasing worldwide [2], in part due to the UNAIDS 90–90–90 strategy [3]. An unanticipated and unforeseeable crisis such as COVID-19, and the extraordinary measures taken to fight it may have substantial effects on the rising trends in STIs and declining trends in HIV. So far, at the largest Tertiary Teaching Hospital in Portugal, we are yet to see a reduction in the number of patients with venereal complaints who present to our Dermatology and Venereology Emergency Consultation. However, we must stress that rigorous social isolation measures have only been taken one week prior to the date of writing, which means it’s too early to draw any conclusions. Nevertheless, smartphone apps dedicated to dating and sexual meetings continue to run at full pace during this time of reclusion, which may limit the efficacy of imposed measures in controlling the SARS-CoV-2 pandemic, and may impact the reduction in STI incidence during this period. The measures taken to contain and mitigate the spread of SARS-CoV-2 may also have an impact on the professional activity of sex workers. Apart from the economical impact on these workers, fewer casual intercourse occasions in this context may further alter the individual risk for HIV infection as well as for other STIs. Further thought must be given to the changing social dynamics that influence the ways in which people connect and experience their sexuality. As sexual health is a fundamental determinant for the wellbeing of human beings, it is not plausible to assume that sexual contacts will cease for the duration of the SARS-CoV-2 pandemic. However, sexual experiences are a complex interplay of physical, visual, auditive and psychological stimuli, that doesn’t require physical contact in every instance. Indeed, for a generation that is used to communicating with each other through social media, we must also analyze the impact of this pandemic on the way people experience sexuality. It may be the case that people will turn to sexting, face-time, and other such practices as sexual outlets during conditions of limited direct physical contact. While this phenomenon is not intrinsically detrimental, we must be aware of the higher risks for crimes related to exploitation, unauthorized diffusion of personal information and images as well as their significant impact on mental health [4, 5]. Furthermore, should this situation be maintained for a prolonged period of time, we must ask whether these new practices shape the way people sexually interact in the future. That is, will the social measures taken in response to SARS-CoV-2 change social interactions in such a way that behavioral practices that may reduce or possibly increase risks for STI persist or subside? A final point that cannot be overlooked is the way we provide care for people living with HIV as well as patients presenting with STIs during these challenging times. In our center, most appointments have been cancelled to reduce exposure of patients to high risk environments, as well as to allow health personnel to be mobilized to COVID-19 patient care. Nevertheless, our HIV and other STI patients still require monitoring and medical care. We have found that our Dermatology and Venereology Emergency Consultation, diverted away from the internal circuits for other Emergency Department complaints constitutes a useful and risk-reducing service for acute venereal complaints. As for our patients with HIV, we are finding that the patient–doctor relationships that naturally develop over the time with chronic conditions allows for most routine appointments to be conducted over the phone, and when necessary, in-person observation can be arranged in the most appropriate setting to reduce the risk of SARS-CoV-2 infection. The SARS-CoV-2 pandemic may be more far reaching than the immediate public health concerns. It remains to be seen if changes in STI incidence will be a silver lining to this tragedy, or if the changes in the way people live their sexuality will prove to be maladaptive and risk promoting. We suggest that a holistic approach be adopted while dealing with this pandemic, to assure the fullest extent of health.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Not a luxury: a call to maintain sexual and reproductive health in humanitarian and fragile settings during the COVID-19 pandemic

              About 1·8 billion people live in fragile contexts worldwide, 1 including 168 million individuals in need of humanitarian assistance. Approximately a quarter of those in fragile contexts are women and girls of reproductive age. 2 Experience from past epidemics in these settings has showed that discontinuing health-care services deemed unrelated to the epidemic response resulted in more deaths than did the epidemic itself. 3 Issues related to sexual and reproductive health are among the leading causes of mortality and morbidity among women of childbearing age, with countries affected by fragility and crisis accounting for 61% of maternal deaths worldwide. 4 Poor health outcomes will surge from the absence or disruption of lifesaving services, including emergency obstetric and newborn care, contraception to prevent unwanted pregnancies, and the management of abortion complications. Gender-based violence and sexual exploitation and abuse might increase during outbreaks because of confinement, increased exposure to perpetrators at home, economic precarity, and reduced access to protection services. The care for children and others confined at home further reduces women's ability to properly care for themselves. 5 In the context of the pandemic preparedness and response, members of the Inter-Agency Working Group for Reproductive Health in Crises have issued various field guidance documents on sexual and reproductive health and coronavirus disease 2019 (COVID-19). Building on the overarching need for humanitarian actors to coordinate and plan to ensure that sexual and reproductive health is integrated into the pandemic preparedness and response, 6 there are four prongs on how to mitigate the impact of COVID-19 on mortality and morbidity due to sexual and reproductive health conditions in crisis and in fragile settings. First, with the understanding that the risks of adverse outcomes from medical complications outweigh the potential risks of COVID-19 transmission at health facilities, the availability of all crucial services and supplies as defined by the Minimum Initial Services Package for sexual and reproductive health should continue. 6 These services include intrapartum care for all births and emergency obstetric and newborn care (caesarean sections should only be performed when medically indicated as a COVID-19 positive status is not an indication for a caesarean section 7 ), post-abortion care, safe abortion care to the full extent of the law, contraception, clinical care for rape survivors, and prevention and treatment for HIV and other sexually transmitted infections. Early and exclusive breastfeeding and skin-to-skin contact for neonates should be promoted, and mother and neonate should not be separated unless one or both are critically ill in cases of suspected or confirmed COVID-19 infections. 7 Second, comprehensive sexual and reproductive health services should continue as long as the system is not overstretched with COVID-19 case management. For relevant consultations and follow-up, remote approaches should be considered where feasible (eg, telephone, digital applications, text messaging). In addition to the Minimum Initial Service Package, these comprehensive services—ie, all antenatal care, postnatal care, newborn care, breastfeeding support, and cervical cancer screening, as well as care for individuals experiencing intimate partner violence—should remain available to all individuals who need them, including adolescents. Third, clear, consistent, and updated public health information crafted with representatives of the targeted audiences should reach the community and health-care workers. This information should reaffirm that medical complications outweigh the potential risk of transmission at health facilities and that community members should continue to seek and receive care during childbirth and for all other essential sexual and reproductive health needs or emergencies resulting from other diseases, trauma, or violence. The community should understand that any changes in routine services are for patients' benefit to ensure support to the COVID-19 response, avert undue exposure to the risk of contracting the virus in a health facility during the outbreak, or both. However, the coordination and planning to re-establish such comprehensive services should occur as soon as the situation stabilises. Fourth, COVID-19 infection prevention and control precautions, including hand hygiene, physical distancing, and respiratory etiquette should apply to patients (and accompanying family members if their presence is necessary). Additionally, staff should be protected with adequate personal protective equipment. Facilities also need to establish a patient flow that incorporates triage before entrance into the facility, and an isolation area and separate consultation room for suspected or confirmed cases. To minimise preventable deaths, crucial health-care services, including sexual and reproductive health services, should remain accessible during public health emergencies, even when resources from already fragile health systems are often redirected for outbreak response. The COVID-19 pandemic will magnify the risks inherent to resource reshuffling at the expense of other services; however, sexual and reproductive health cannot be viewed as a luxury. 8 On March 31, 2020, the United Nations Secretary-General highlighted in relation to COVID-19 that “we are only as strong as the weakest health system in our interconnected world”. 9 To echo this statement, we have offered guidance on sexual and reproductive health and COVID-19, and we call on health authorities to prioritise these lifesaving services in humanitarian and fragile settings. Such interventions should be considered as indispensable components of health services that do not strain, but strengthen health systems during COVID-19 preparedness and response efforts. The collective health of women, girls, and the wider community depends on these services.
                Bookmark

                Author and article information

                Contributors
                ilsabo@libero.it
                Journal
                J Eur Acad Dermatol Venereol
                J Eur Acad Dermatol Venereol
                10.1111/(ISSN)1468-3083
                JDV
                Journal of the European Academy of Dermatology and Venereology
                John Wiley and Sons Inc. (Hoboken )
                0926-9959
                1468-3083
                27 July 2020
                : 10.1111/jdv.16808
                Affiliations
                [ 1 ] Division of Dermatology STI Clinic Santa Chiara Hospital Trento Italy
                [ 2 ] Private Practice Trento Italy
                Author notes
                [*] [* ] Correspondence: R. Balestri. E-mail: ilsabo@ 123456libero.it

                Author information
                https://orcid.org/0000-0002-0885-054X
                https://orcid.org/0000-0001-9429-9004
                Article
                JDV16808
                10.1111/jdv.16808
                7405161
                32652791
                b218b26a-9265-4650-a729-8c30748dc255
                © 2020 European Academy of Dermatology and Venereology

                This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

                History
                : 23 June 2020
                : 03 July 2020
                Page count
                Figures: 0, Tables: 1, Pages: 2, Words: 2082
                Categories
                Letter To The Editor
                Letter to the Editors
                Custom metadata
                2.0
                corrected-proof
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.6 mode:remove_FC converted:05.08.2020

                Dermatology
                Dermatology

                Comments

                Comment on this article